Humana (HUM) PT Lowered to $515 at Jefferies on Weak Guidance

July 29, 2021 8:43 AM EDT
Get Alerts HUM Hot Sheet
Price: $407.79 +2.16%

Rating Summary:
    18 Buy, 15 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Jefferies analyst David Windley lowered the price target on Humana (NYSE: HUM) to $515.00 (from $525.00) after the company reported results that met expectations but guided below baseline.

The analyst reiterated a Buy rating, stating "Mgt plotted a "reasonable path" to '21 guidance, and we think a few paths could work. However, they seem a shade (not wildly) optimistic, based on cost trends discussed. Key questions both for 2H21 and solid growth in '22 revolve around: 1) the reasonableness of mgt's 2.5% below baseline utilization assumption, and 2) the interplay of COVID infection rates/costs and non-COVID utilization"."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co